Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
Crossref DOI link: https://doi.org/10.1186/s13045-016-0371-1
Published Online: 2017-01-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Massihnia, Daniela
Avan, Amir
Funel, Niccola
Maftouh, Mina
van Krieken, Anne
Granchi, Carlotta
Raktoe, Rajiv
Boggi, Ugo
Aicher, Babette
Minutolo, Filippo
Russo, Antonio
Leon, Leticia G.
Peters, Godefridus J.
Giovannetti, Elisa